Cargando…

Terminal Schwann cells at the human neuromuscular junction

Terminal Schwann cells are non-myelinating glial cells localized to the neuromuscular junction. They play an important role in regulating many aspects of neuromuscular junction form and function, in health and during disease. However, almost all previous studies of mammalian terminal Schwann cells h...

Descripción completa

Detalles Bibliográficos
Autores principales: Alhindi, Abrar, Boehm, Ines, Forsythe, Rachael O, Miller, Janice, Skipworth, Richard J E, Simpson, Hamish, Jones, Ross A, Gillingwater, Thomas H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093923/
https://www.ncbi.nlm.nih.gov/pubmed/33977269
http://dx.doi.org/10.1093/braincomms/fcab081
_version_ 1783687915949260800
author Alhindi, Abrar
Boehm, Ines
Forsythe, Rachael O
Miller, Janice
Skipworth, Richard J E
Simpson, Hamish
Jones, Ross A
Gillingwater, Thomas H
author_facet Alhindi, Abrar
Boehm, Ines
Forsythe, Rachael O
Miller, Janice
Skipworth, Richard J E
Simpson, Hamish
Jones, Ross A
Gillingwater, Thomas H
author_sort Alhindi, Abrar
collection PubMed
description Terminal Schwann cells are non-myelinating glial cells localized to the neuromuscular junction. They play an important role in regulating many aspects of neuromuscular junction form and function, in health and during disease. However, almost all previous studies of mammalian terminal Schwann cells have used rodent models. Despite a growing awareness of differences in the cellular and molecular anatomy of rodent and human neuromuscular junctions, it remains unclear as to whether these differences also extend to the terminal Schwann cells. Here, we have adapted immunohistochemical protocols to facilitate visualization and comparative morphometric analyses of terminal Schwann cells at the human and mouse neuromuscular junction. We labelled terminal Schwann cells in the peroneus brevis muscle in six adult mice and five humans with antibodies against S100 protein. All human neuromuscular junctions were associated with at least one terminal Schwann cell, consistent with findings from other species, with an average of ∼1.7 terminal Schwann cells per neuromuscular junction in both humans and mice. In contrast, human terminal Schwann cells were significantly smaller than those of mice (P ≤ 0.01), in keeping with differences in overall synaptic size. Human terminal Schwann cell cytoplasm extended significantly beyond the synaptic boundaries of the neuromuscular junction, whereas terminal Schwann cells in mice were largely restricted to the synapse. Moreover, there was a significant difference in the location of terminal Schwann cell nuclei (P ≤ 0.01), with human terminal Schwann cells having their nuclear compartment located beyond the perimeter of the synapse more than the mouse. Taken together, these findings demonstrate that terminal Schwann cells at the human neuromuscular junction have notable differences in their morphology and synaptic relationships compared to mice. These fundamental differences need to be considered when translating the findings of both neuromuscular junction biology and pathology from rodents to humans.
format Online
Article
Text
id pubmed-8093923
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-80939232021-05-10 Terminal Schwann cells at the human neuromuscular junction Alhindi, Abrar Boehm, Ines Forsythe, Rachael O Miller, Janice Skipworth, Richard J E Simpson, Hamish Jones, Ross A Gillingwater, Thomas H Brain Commun Original Article Terminal Schwann cells are non-myelinating glial cells localized to the neuromuscular junction. They play an important role in regulating many aspects of neuromuscular junction form and function, in health and during disease. However, almost all previous studies of mammalian terminal Schwann cells have used rodent models. Despite a growing awareness of differences in the cellular and molecular anatomy of rodent and human neuromuscular junctions, it remains unclear as to whether these differences also extend to the terminal Schwann cells. Here, we have adapted immunohistochemical protocols to facilitate visualization and comparative morphometric analyses of terminal Schwann cells at the human and mouse neuromuscular junction. We labelled terminal Schwann cells in the peroneus brevis muscle in six adult mice and five humans with antibodies against S100 protein. All human neuromuscular junctions were associated with at least one terminal Schwann cell, consistent with findings from other species, with an average of ∼1.7 terminal Schwann cells per neuromuscular junction in both humans and mice. In contrast, human terminal Schwann cells were significantly smaller than those of mice (P ≤ 0.01), in keeping with differences in overall synaptic size. Human terminal Schwann cell cytoplasm extended significantly beyond the synaptic boundaries of the neuromuscular junction, whereas terminal Schwann cells in mice were largely restricted to the synapse. Moreover, there was a significant difference in the location of terminal Schwann cell nuclei (P ≤ 0.01), with human terminal Schwann cells having their nuclear compartment located beyond the perimeter of the synapse more than the mouse. Taken together, these findings demonstrate that terminal Schwann cells at the human neuromuscular junction have notable differences in their morphology and synaptic relationships compared to mice. These fundamental differences need to be considered when translating the findings of both neuromuscular junction biology and pathology from rodents to humans. Oxford University Press 2021-04-15 /pmc/articles/PMC8093923/ /pubmed/33977269 http://dx.doi.org/10.1093/braincomms/fcab081 Text en © The Author(s) (2021). Published by Oxford University Press on behalf of the Guarantors of Brain. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Alhindi, Abrar
Boehm, Ines
Forsythe, Rachael O
Miller, Janice
Skipworth, Richard J E
Simpson, Hamish
Jones, Ross A
Gillingwater, Thomas H
Terminal Schwann cells at the human neuromuscular junction
title Terminal Schwann cells at the human neuromuscular junction
title_full Terminal Schwann cells at the human neuromuscular junction
title_fullStr Terminal Schwann cells at the human neuromuscular junction
title_full_unstemmed Terminal Schwann cells at the human neuromuscular junction
title_short Terminal Schwann cells at the human neuromuscular junction
title_sort terminal schwann cells at the human neuromuscular junction
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093923/
https://www.ncbi.nlm.nih.gov/pubmed/33977269
http://dx.doi.org/10.1093/braincomms/fcab081
work_keys_str_mv AT alhindiabrar terminalschwanncellsatthehumanneuromuscularjunction
AT boehmines terminalschwanncellsatthehumanneuromuscularjunction
AT forsytherachaelo terminalschwanncellsatthehumanneuromuscularjunction
AT millerjanice terminalschwanncellsatthehumanneuromuscularjunction
AT skipworthrichardje terminalschwanncellsatthehumanneuromuscularjunction
AT simpsonhamish terminalschwanncellsatthehumanneuromuscularjunction
AT jonesrossa terminalschwanncellsatthehumanneuromuscularjunction
AT gillingwaterthomash terminalschwanncellsatthehumanneuromuscularjunction